Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Luxembourg
Luxembourg: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 97.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Luxembourg, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Luxembourg stood at 97.0%. That is the highest value across all 18 years on record.
That represents a change of up 2.1% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Luxembourg peaked at 97.0% in 2022 and was at its lowest, 86.0%, in 2008.
That places Luxembourg 17th out of 194 countries with data for 2025, putting it in the top 10%.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 86.0% | 86.0% | 86.0% | 2 |
| 2010s | 93.4% | 86.0% | 96.0% | 10 |
| 2020s | 96.7% | 96.0% | 97.0% | 6 |
Countries ranked near Luxembourg
More health data for Luxembourg
- Heat deaths vs projected death rates 1,220 (2090)
- Un projection of annual infant deaths 4 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 4,324 (2025)
- Age population, age 25, female, interpolated 4,054 (2025)
- Age population, age 24, male, interpolated 4,062 (2025)
- Age population, age 24, female, interpolated 3,875 (2025)
- Age population, age 23, male, interpolated 3,866 (2025)
- Age population, age 23, female, interpolated 3,695 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Luxembourg?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Luxembourg was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Luxembourg?
- The highest recorded value was 97.0% in 2022.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Luxembourg?
- The lowest recorded value was 86.0% in 2008.
- How does Luxembourg rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Luxembourg ranks 17th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Luxembourg?
- Over the last ten years it is up 2.1%. The long-run trend across the full record is rising.
- Where does this Luxembourg data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).